Physiological  ||| S:0 E:14 ||| NNP
and  ||| S:14 E:18 ||| CC
Histological  ||| S:18 E:31 ||| NNP
Evaluations  ||| S:31 E:43 ||| NNP
of  ||| S:43 E:46 ||| IN
the  ||| S:46 E:50 ||| DT
Cochlea  ||| S:50 E:58 ||| NNP
between  ||| S:58 E:66 ||| IN
3xTg-AD  ||| S:66 E:74 ||| NNP
Mouse  ||| S:74 E:80 ||| NNP
Model  ||| S:80 E:86 ||| NNP
of  ||| S:86 E:89 ||| IN
Alzheimer ||| S:89 E:98 ||| NNP
's  ||| S:98 E:101 ||| POS
Diseases  ||| S:101 E:110 ||| NNP
and  ||| S:110 E:114 ||| CC
R6 ||| S:114 E:116 ||| CD
/ ||| S:116 E:117 ||| CD
2  ||| S:117 E:119 ||| CD
Mouse  ||| S:119 E:125 ||| NNP
Model  ||| S:125 E:131 ||| NNP
of  ||| S:131 E:134 ||| IN
Huntington ||| S:134 E:144 ||| NNP
's  ||| S:144 E:147 ||| POS
Diseases  ||| S:147 E:156 ||| NNP
Patients  ||| S:156 E:165 ||| NNPS
with  ||| S:165 E:170 ||| IN
Alzheimer ||| S:170 E:179 ||| NNP
's  ||| S:179 E:182 ||| POS
diseases  ||| S:182 E:191 ||| NNS
( ||| S:191 E:192 ||| -LRB-
AD ||| S:192 E:194 ||| NNP
)  ||| S:194 E:196 ||| -RRB-
and  ||| S:196 E:200 ||| CC
Huntington ||| S:200 E:210 ||| NNP
's  ||| S:210 E:213 ||| POS
diseases  ||| S:213 E:222 ||| NNS
( ||| S:222 E:223 ||| -LRB-
HD ||| S:223 E:225 ||| NNP
)  ||| S:225 E:227 ||| -RRB-
are  ||| S:227 E:231 ||| VBP
known  ||| S:231 E:237 ||| VBN
to  ||| S:237 E:240 ||| TO
have  ||| S:240 E:245 ||| VB
abnormal  ||| S:245 E:254 ||| JJ
auditory  ||| S:254 E:263 ||| JJ
processing ||| S:263 E:273 ||| NN
,  ||| S:273 E:275 ||| ,
but  ||| S:275 E:279 ||| CC
the  ||| S:279 E:283 ||| DT
physiological  ||| S:283 E:297 ||| NN
and  ||| S:297 E:301 ||| CC
histological  ||| S:301 E:314 ||| JJ
evaluations  ||| S:314 E:326 ||| NNS
of  ||| S:326 E:329 ||| IN
the  ||| S:329 E:333 ||| DT
cochlea  ||| S:333 E:341 ||| NN
between  ||| S:341 E:349 ||| IN
AD  ||| S:349 E:352 ||| NNP
and  ||| S:352 E:356 ||| CC
HD  ||| S:356 E:359 ||| NNP
have  ||| S:359 E:364 ||| VBP
not  ||| S:364 E:368 ||| RB
been  ||| S:368 E:373 ||| VBN
thoroughly  ||| S:373 E:384 ||| RB
assessed ||| S:384 E:392 ||| VBN
.  ||| S:392 E:394 ||| .
Thus  ||| S:394 E:399 ||| RB
we  ||| S:399 E:402 ||| PRP
assessed  ||| S:402 E:411 ||| VBD
the  ||| S:411 E:415 ||| DT
auditory  ||| S:415 E:424 ||| JJ
brainstem  ||| S:424 E:434 ||| JJ
response  ||| S:434 E:443 ||| NN
( ||| S:443 E:444 ||| -LRB-
ABR ||| S:444 E:447 ||| NNP
)  ||| S:447 E:449 ||| -RRB-
and  ||| S:449 E:453 ||| CC
distortion  ||| S:453 E:464 ||| JJ
product  ||| S:464 E:472 ||| NN
otoacoustic  ||| S:472 E:484 ||| NN
emissions  ||| S:484 E:494 ||| NNS
( ||| S:494 E:495 ||| -LRB-
DPOAE ||| S:495 E:500 ||| NNP
) ||| S:500 E:501 ||| -RRB-
,  ||| S:501 E:503 ||| ,
and  ||| S:503 E:507 ||| CC
then  ||| S:507 E:512 ||| RB
examined  ||| S:512 E:521 ||| FW
spiral  ||| S:521 E:528 ||| FW
ganglion  ||| S:528 E:537 ||| FW
neurons  ||| S:537 E:545 ||| FW
( ||| S:545 E:546 ||| -LRB-
SGNs ||| S:546 E:550 ||| NNP
)  ||| S:550 E:552 ||| -RRB-
and  ||| S:552 E:556 ||| CC
hair  ||| S:556 E:561 ||| NN
cells  ||| S:561 E:567 ||| NNS
in  ||| S:567 E:570 ||| IN
the  ||| S:570 E:574 ||| DT
cochlea  ||| S:574 E:582 ||| NN
using  ||| S:582 E:588 ||| VBG
3xTg-AD  ||| S:588 E:596 ||| CD
mouse  ||| S:596 E:602 ||| NN
model  ||| S:602 E:608 ||| NN
of  ||| S:608 E:611 ||| IN
AD  ||| S:611 E:614 ||| NNP
and  ||| S:614 E:618 ||| CC
R6 ||| S:618 E:620 ||| CD
/ ||| S:620 E:621 ||| CD
2-HD  ||| S:621 E:626 ||| CD
mouse  ||| S:626 E:632 ||| NN
model  ||| S:632 E:638 ||| NN
of  ||| S:638 E:641 ||| IN
HD ||| S:641 E:643 ||| NNP
.  ||| S:643 E:645 ||| .
We  ||| S:645 E:648 ||| PRP
found  ||| S:648 E:654 ||| VBD
that  ||| S:654 E:659 ||| IN
the  ||| S:659 E:663 ||| DT
threshold  ||| S:663 E:673 ||| NN
of  ||| S:673 E:676 ||| IN
ABR ||| S:676 E:679 ||| NNP
,  ||| S:679 E:681 ||| ,
but  ||| S:681 E:685 ||| CC
not  ||| S:685 E:689 ||| RB
DPOAE ||| S:689 E:694 ||| NNP
,  ||| S:694 E:696 ||| ,
was  ||| S:696 E:700 ||| VBD
significantly  ||| S:700 E:714 ||| RB
increased  ||| S:714 E:724 ||| VBN
in  ||| S:724 E:727 ||| IN
AD  ||| S:727 E:730 ||| NNP
mice  ||| S:730 E:735 ||| NNS
from  ||| S:735 E:740 ||| IN
9  ||| S:740 E:742 ||| CD
months  ||| S:742 E:749 ||| NNS
of  ||| S:749 E:752 ||| IN
age  ||| S:752 E:756 ||| NN
and  ||| S:756 E:760 ||| CC
thereafter ||| S:760 E:770 ||| RB
.  ||| S:770 E:772 ||| .
The  ||| S:772 E:776 ||| DT
significant  ||| S:776 E:788 ||| JJ
loss  ||| S:788 E:793 ||| NN
of  ||| S:793 E:796 ||| IN
SGNs ||| S:796 E:800 ||| NNP
,  ||| S:800 E:802 ||| ,
but  ||| S:802 E:806 ||| CC
not  ||| S:806 E:810 ||| RB
hair  ||| S:810 E:815 ||| JJ
cells ||| S:815 E:820 ||| NNS
,  ||| S:820 E:822 ||| ,
was  ||| S:822 E:826 ||| VBD
observed  ||| S:826 E:835 ||| VBN
in  ||| S:835 E:838 ||| IN
the  ||| S:838 E:842 ||| DT
cochlea  ||| S:842 E:850 ||| NN
of  ||| S:850 E:853 ||| IN
9-  ||| S:853 E:856 ||| NNP
and  ||| S:856 E:860 ||| CC
12-month  ||| S:860 E:869 ||| JJ
AD  ||| S:869 E:872 ||| NN
mice ||| S:872 E:876 ||| NNS
.  ||| S:876 E:878 ||| .
On  ||| S:878 E:881 ||| IN
the  ||| S:881 E:885 ||| DT
other  ||| S:885 E:891 ||| JJ
hand ||| S:891 E:895 ||| NN
,  ||| S:895 E:897 ||| ,
we  ||| S:897 E:900 ||| PRP
found  ||| S:900 E:906 ||| VBD
that  ||| S:906 E:911 ||| IN
both  ||| S:911 E:916 ||| DT
ABR  ||| S:916 E:920 ||| NNP
and  ||| S:920 E:924 ||| CC
DPOAE  ||| S:924 E:930 ||| NNP
thresholds  ||| S:930 E:941 ||| NN
were  ||| S:941 E:946 ||| VBD
significantly  ||| S:946 E:960 ||| RB
increased  ||| S:960 E:970 ||| VBN
in  ||| S:970 E:973 ||| IN
HD  ||| S:973 E:976 ||| NNP
mice  ||| S:976 E:981 ||| NNS
from  ||| S:981 E:986 ||| IN
2  ||| S:986 E:988 ||| CD
months  ||| S:988 E:995 ||| NNS
of  ||| S:995 E:998 ||| IN
age  ||| S:998 E:1002 ||| NN
and  ||| S:1002 E:1006 ||| CC
thereafter ||| S:1006 E:1016 ||| RB
.  ||| S:1016 E:1018 ||| .
The  ||| S:1018 E:1022 ||| DT
large  ||| S:1022 E:1028 ||| JJ
loss  ||| S:1028 E:1033 ||| NN
of  ||| S:1033 E:1036 ||| IN
hair  ||| S:1036 E:1041 ||| NN
cells  ||| S:1041 E:1047 ||| NNS
and  ||| S:1047 E:1051 ||| CC
the  ||| S:1051 E:1055 ||| DT
small  ||| S:1055 E:1061 ||| JJ
loss  ||| S:1061 E:1066 ||| NN
of  ||| S:1066 E:1069 ||| IN
SGNs  ||| S:1069 E:1074 ||| NNP
were  ||| S:1074 E:1079 ||| VBD
observed  ||| S:1079 E:1088 ||| VBN
in  ||| S:1088 E:1091 ||| IN
the  ||| S:1091 E:1095 ||| DT
cochlea  ||| S:1095 E:1103 ||| NN
of  ||| S:1103 E:1106 ||| IN
3-month  ||| S:1106 E:1114 ||| NNP
HD  ||| S:1114 E:1117 ||| NNP
mice ||| S:1117 E:1121 ||| NNS
.  ||| S:1121 E:1123 ||| .
Furthermore ||| S:1123 E:1134 ||| RB
,  ||| S:1134 E:1136 ||| ,
the  ||| S:1136 E:1140 ||| DT
prestin  ||| S:1140 E:1148 ||| JJ
expression  ||| S:1148 E:1159 ||| NN
in  ||| S:1159 E:1162 ||| IN
outer  ||| S:1162 E:1168 ||| JJ
hair  ||| S:1168 E:1173 ||| NN
cells  ||| S:1173 E:1179 ||| NNS
( ||| S:1179 E:1180 ||| -LRB-
OHCs ||| S:1180 E:1184 ||| NNP
)  ||| S:1184 E:1186 ||| -RRB-
was  ||| S:1186 E:1190 ||| VBD
significantly  ||| S:1190 E:1204 ||| RB
decreased  ||| S:1204 E:1214 ||| VBN
in  ||| S:1214 E:1217 ||| IN
HD  ||| S:1217 E:1220 ||| NNP
mice  ||| S:1220 E:1225 ||| NNS
from  ||| S:1225 E:1230 ||| IN
2  ||| S:1230 E:1232 ||| CD
months  ||| S:1232 E:1239 ||| NNS
of  ||| S:1239 E:1242 ||| IN
age  ||| S:1242 E:1246 ||| NN
and  ||| S:1246 E:1250 ||| CC
thereafter ||| S:1250 E:1260 ||| RB
,  ||| S:1260 E:1262 ||| ,
and  ||| S:1262 E:1266 ||| CC
the  ||| S:1266 E:1270 ||| DT
loss  ||| S:1270 E:1275 ||| NN
of  ||| S:1275 E:1278 ||| IN
prestin  ||| S:1278 E:1286 ||| JJ
expression  ||| S:1286 E:1297 ||| NN
was  ||| S:1297 E:1301 ||| VBD
earlier  ||| S:1301 E:1309 ||| RBR
before  ||| S:1309 E:1316 ||| IN
OHCs  ||| S:1316 E:1321 ||| JJ
death  ||| S:1321 E:1327 ||| NN
in  ||| S:1327 E:1330 ||| IN
HD  ||| S:1330 E:1333 ||| NNP
mice ||| S:1333 E:1337 ||| NNS
.  ||| S:1337 E:1339 ||| .
Different  ||| S:1339 E:1349 ||| JJ
from  ||| S:1349 E:1354 ||| IN
HD  ||| S:1354 E:1357 ||| NNP
mice ||| S:1357 E:1361 ||| NNS
,  ||| S:1361 E:1363 ||| ,
the  ||| S:1363 E:1367 ||| DT
prestin  ||| S:1367 E:1375 ||| JJ
expression  ||| S:1375 E:1386 ||| NN
in  ||| S:1386 E:1389 ||| IN
OHCs  ||| S:1389 E:1394 ||| JJ
in  ||| S:1394 E:1397 ||| IN
AD  ||| S:1397 E:1400 ||| NNP
mice  ||| S:1400 E:1405 ||| NNS
was  ||| S:1405 E:1409 ||| VBD
not  ||| S:1409 E:1413 ||| RB
changed  ||| S:1413 E:1421 ||| VBN
even  ||| S:1421 E:1426 ||| RB
at  ||| S:1426 E:1429 ||| IN
12  ||| S:1429 E:1432 ||| CD
months  ||| S:1432 E:1439 ||| NNS
of  ||| S:1439 E:1442 ||| IN
age ||| S:1442 E:1445 ||| NN
.  ||| S:1445 E:1447 ||| .
Our  ||| S:1447 E:1451 ||| PRP$
data  ||| S:1451 E:1456 ||| NNS
suggest  ||| S:1456 E:1464 ||| VBP
that  ||| S:1464 E:1469 ||| IN
cochlear  ||| S:1469 E:1478 ||| JJ
pathology  ||| S:1478 E:1488 ||| NNS
contributing  ||| S:1488 E:1501 ||| VBG
to  ||| S:1501 E:1504 ||| TO
hearing  ||| S:1504 E:1512 ||| NN
loss  ||| S:1512 E:1517 ||| NN
is  ||| S:1517 E:1520 ||| VBZ
quite  ||| S:1520 E:1526 ||| RB
different  ||| S:1526 E:1536 ||| JJ
between  ||| S:1536 E:1544 ||| IN
transgenic  ||| S:1544 E:1555 ||| JJ
mice  ||| S:1555 E:1560 ||| NNS
of  ||| S:1560 E:1563 ||| IN
AD  ||| S:1563 E:1566 ||| NNP
and  ||| S:1566 E:1570 ||| CC
HD ||| S:1570 E:1572 ||| NNP
.  ||| S:1572 E:1574 ||| .
More  ||| S:1574 E:1579 ||| RBR
detailed  ||| S:1579 E:1588 ||| JJ
pathological  ||| S:1588 E:1601 ||| JJ
mechanisms  ||| S:1601 E:1612 ||| NNS
for  ||| S:1612 E:1616 ||| IN
hearing  ||| S:1616 E:1624 ||| NN
loss  ||| S:1624 E:1629 ||| NN
between  ||| S:1629 E:1637 ||| IN
AD  ||| S:1637 E:1640 ||| NNP
and  ||| S:1640 E:1644 ||| CC
HD  ||| S:1644 E:1647 ||| NNP
need  ||| S:1647 E:1652 ||| VBP
further  ||| S:1652 E:1660 ||| JJ
study ||| S:1660 E:1665 ||| NN
.  ||| S:1665 E:1667 ||| .
